ADVERTISEMENT

cardiotoxicity

Research in Review

Cardiotoxicity Among Childhood Cancer Survivors Decreasing Over Time

01/24/2017

JCP Editors

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

Initiatives to reduce cardiotoxicity among childhood patients with cancer treated more recently have had a measurable impact over time, according to research published in Circulation. ----- Related Content Risk of...

...

01/24/2017

Journal of Clinical Pathways

Research in Review

Trastuzumab-Related Cardiotoxicity Prevented In Patients With Breast Cancer

11/30/2016

JCP Editors

Two kinds of heart medications, angiotensin-converting enzyme (ACE) inhibitors and beta blockers, can help to prevent a decline in heart function from breast cancer treatment, according to new research published in...

Two kinds of heart medications, angiotensin-converting enzyme (ACE) inhibitors and beta blockers, can help to prevent a decline in heart function from breast cancer treatment, according to new research published in...

Two...

11/30/2016

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

DCLF

March 17 ⁠–⁠ March 19

See Full Calendar

Advertisement

Advertisement